Q1’s 4th Annual Pharma & Biotech Medical Affairs Pre-Launch Strategies Conference taking place on April 29-30 features a mix of industry perspectives from experts, including Daniel Snyder of Revance Therapeutics, Inc.

Michael Sullivan, an expert in sales training, is presenting at Q1 Production’s 9th Annual Pharmaceutical Sales Training Conference in March.

Technology is always changing. From new cell phones that help you connect to rockets that go out in to the universe. Technology empowers people to be innovative and create the best results. Stability testing is no different

Many industries require discretion and integrity. Stability testing is no different. One of the hottest topics in the stability industry is data integrity. Although this is not a new concept, new guidances have been put in place from the FDA. Data integrity is the...

In November 2016, ICH published an addendum to its guidelines for clinical practice, prompting pharmaceutical companies to align current clinical quality procedures with a risk-based monitoring approach.

Recent debates surrounding drug pricing have forced the pharmaceutical industry to navigate multiple avenues ensuring optimal coverage while maintaining high levels of ROI. Though the industry has worked extensively with insurance providers, building positive...

Will 2018 be Pharma’s Greatest Year Yet?   The pharmaceutical industry has faced many changes in 2017. Legislative uncertainty, patient-centricity, and ransomware threats are just a few of the industry’s hurdles so far. Looking ahead, however, the industry may be...

Forecasting Legislation and Industry Changes in the Trump Administration   With the recent passing of the American Health Care Act (AHCA) through the U.S. House of Representatives, many industry leaders are anticipating the possible changes the AHCA may bring....

How the Patient Centricity is Changing the Pharmaceutical Industry   Over the past few years, drug makers have partnered with patients to deliver better drugs, gain more feedback, and provide more information about their products. This renewed focus on patient...

What Pharma Can Learn from WannaCry   Over the past two weeks, healthcare networks across the globe have been infiltrated and patient data has been locked. These attacks, which are all connected to WannaCry ransomware, have spurred a conversation about what...